Product Dossier
APO-CITALOPRAM
Product Dossier for APO-CITALOPRAM (citalopram hydrobromide, Arrotex Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: citalopram hydrobromide
- Therapeutic area: Psychiatry
- Related brand: CIPRAMIL
- Same area: REXULTI
- Same area: NICORETTE
I appreciate the detailed instructions for creating this
Brand Dossier. However, I can only complete this task with the information provided in the source documents.
The available source document contains only ARTG registration details for APO-CITALOPRAM, including the brand name, sponsor, strengths, and registration dates. To write a comprehensive Brand Dossier according to your specifications, I would need source documents that contain information about: — Clinical indication(s) — Dosing recommendations — Safety warnings and contraindications — PBS listing details (if applicable) — Regulatory history (PBAC outcomes, AusPAR information, etc.)
Based solely on the ARTG registration data provided, I can only confirm:
What it is
APO-CITALOPRAM is a citalopram hydrobromide tablet formulation sponsored by Arrotex Pharmaceuticals. Without additional source documents containing clinical, safety, PBS, and regulatory information, I cannot complete the remaining required sections (Approved indications, Dosing overview, Key safety warnings, Contraindications, PBS listing, and Regulatory history) in accordance with your instruction that every factual claim must be supported by provided source documents.
Please provide the additional source materials needed to complete this dossier.